2 unknown, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Terminated 1 |
Follow Inhibition, Psychological: new trials by email Literature Review of Inhibition, Psychological trials Research Report on Inhibition, Psychological
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients Methotrexate Tablets, Tofacitinib tablet - Takayasu Arteritis, Methotrexate | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 130 | 2020-03-01 | 2020-06-12 |
| The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study Ambrisentan plus Spironolactone, Ambrisentan plus Placebo - Pulmonary Arterial Hypertension | Phase 4 | Terminated | Brigham and Women's Hospital | 2 | 2015-09-01 | 2019-11-15 |
| Evaluation Effects of Treatment With IL-6R Inhibitor on Clinical Response and Biomarkers in Patients With Rheumatoid Arthritis (RA) Not Responding to DMARDs and/or a First Biological Agent. Biomarkers Measures - Rheumatoid Arthritis (RA) | Phase 4 | Unknown | Osservatorio Epidemiologico GISEA | 150 | 2013-01-01 | 2013-04-19 |
Arthritis, Rheumatoid (1) · Heart Failure (1) · Pulmonary Arterial Hypertension (1) · Takayasu Arteritis (1)
Behavior (3) · Cardiovascular Diseases (2) · Skin and Connective Tissue Diseases (2) · Aortic Arch Syndromes (1) · Aortic Diseases (1) · Arteritis (1) · Arthritis (1) · Autoimmune Diseases (1) · Connective Tissue Diseases (1) · Heart Diseases (1) · Hypertension, Pulmonary (1) · Immune System Diseases (1) · Joint Diseases (1) · Lung Diseases (1) · Musculoskeletal Diseases (1)
Methotrexate (1) · Spironolactone (1) · ambrisentan (1) · tofacitinib (1)
Brigham and Women's Hospital (1) · Osservatorio Epidemiologico GISEA (1) · Shanghai Zhongshan Hospital (1)
China (1) · Italy (1) · United States (1)
Bradley Maron, MD (1) · Gianfranco Ferraccioli, Prof. (1) · Lindi Jiang, PhD (1)